Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance

SanBio To Press On Despite Trial Failure

 
• By Ian Haydock
  
Broken deal
SanBio Considers Options After End Of Cell Therapy Deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business